Mike was told in the fall of 2010 that Pfizer was closing the Allergy & Respiratory diseases programs and his own role as the CSO of this group was being eliminated. Rather than seek employment elsewhere, Mike had others ideas.
https://www.forbes.com/sites/johnlamattina/2017/03/15/turning-pfizer-discards-into-novartis-gold-the-story-of-ziarco/#705216187572
No comments:
Post a Comment